# Dexamethasone in the Prevention of Post-spinal Paralytic Ileus After Cesarean Section

> **NCT05654649** · PHASE1,PHASE2 · RECRUITING · sponsor: **Assiut University** · enrollment: 90 (estimated)

## Conditions studied

- Postoperative Ileus

## Interventions

- **DRUG:** 0.9%sodium chloride
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT05654649
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05654649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05654649, "Dexamethasone in the Prevention of Post-spinal Paralytic Ileus After Cesarean Section". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05654649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*